Birdsall Gavin A, Lee Michael J
Department of Systems Biology, UMass Chan Medical School.
Department of Systems Biology, UMass Chan Medical School;
J Vis Exp. 2025 Jun 6(220). doi: 10.3791/67768.
For understanding drug efficacy, a critical need is to characterize the extent of drug-induced cell death. Efforts to quantify the level of drug-induced cell death are challenged by the existence of more than a dozen molecularly distinct forms of regulated death, each with its own activation timing and biochemical hallmark features. Furthermore, for some necrotic death subtypes, hallmark features are only observed transiently and are rapidly lost due to cell rupture. Thus, even when using a combination of death pathway-specific assays, it is challenging to accurately quantify the total amount of cell death or the relative contributions of each death subtype. Another issue is that many death-specific assays ignore how drugs affect cell proliferation, making it challenging to interpret if a drug-treated population is expanding or shrinking. The FLICK assay allows for quantification of the total level of cell death following stimulation in a manner that is specific to death but also largely agnostic to the type(s) of death activated. Additionally, the FLICK assay retains information about the total population size and cell proliferation rate. In this manuscript, we describe the basic use of the FLICK assay, how to troubleshoot this assay when using different types of biological material, and how to use the FLICK assay to quantify the contributions of each type of cell death to an observed drug response.
为了理解药物疗效,一个关键需求是表征药物诱导的细胞死亡程度。由于存在十多种分子上不同的程序性死亡形式,每种形式都有其自身的激活时间和生化特征,因此量化药物诱导的细胞死亡水平的努力面临挑战。此外,对于某些坏死性死亡亚型,特征仅短暂观察到,并且由于细胞破裂而迅速消失。因此,即使使用死亡途径特异性检测的组合,准确量化细胞死亡总量或每种死亡亚型的相对贡献也具有挑战性。另一个问题是,许多死亡特异性检测忽略了药物如何影响细胞增殖,这使得解释药物处理的群体是在扩大还是在缩小具有挑战性。FLICK检测能够以一种对死亡特异性但对激活的死亡类型基本不敏感的方式,量化刺激后细胞死亡的总水平。此外,FLICK检测保留了有关总体群体大小和细胞增殖率的信息。在本手稿中,我们描述了FLICK检测的基本用途、在使用不同类型生物材料时如何对该检测进行故障排除,以及如何使用FLICK检测来量化每种细胞死亡类型对观察到的药物反应的贡献。